Sleep apnea: Philips remains evasive about its potentially carcinogenic devices

The National Medicines Agency (ANSM) heard from the Dutch group on Wednesday about the case of Philips sleep apnea respirators whose foam is suspected to be a cause of cancer.

Many questions, few answers. In the case of Phillips respirators against sleep apnea, suspected of causing cancer, the National Medicines Agency organized public hearings broadcast live on Wednesday.

Mathieu was in front of his computer for several hours. He was able to watch and listen to toxicologists and epidemiologists answer the questions in this Philips file. Matthew, it was this 45-year-old patient who alerted us to the address In this case. He developed lymph node cancer in early January, while using the brand’s sleep apnea device for five years. On Wednesday, he was relieved to hold the public hearings because he had recently felt forgotten by the authorities.

“I find that it takes a long time to get feedback from organizations like ANSM and the judiciary. It would be interesting to learn a little about where we are. The question remains: Is this machine actually responsible for my disease?”

“We are taken for less than nothing,” the patient is weary

Patients above all expected answers from the Philips managers interviewed. But the latter was satisfied with the clarification that additional tests were underway and that it took time. To technical questions, no answers. Christian Truchot, who chairs the Association of Respiratory Patients, is waiting for other answers.

“What is device foam? What chemical elements is it made of? Have they been replaced on new devices? We have been taken for less than nothing. I think they are playing the card slowly. They have to do that forget. If you have cancer in ten years They will say I have diabetes and I am overweight, and it will go away,” he fears.

Only 20% of devices were replaced in April

Authorities had given Philips until June to replace 75% of its devices. Where are we? Too Far… We don’t yet know the numbers for May, but in April just over 20% of 350,000 sleep apnea devices were replaced, while the Medicines Agency is awash with reports of potential adverse effects. 2,590 reports, including over a hundred on cancers, but also on lung and cardiovascular symptoms.

On the judicial side, there are two ongoing cases. More than 1,200 patients will begin a group civic procedure. They are also a hundred to prepare to file a criminal complaint with their lawyer, Mr. Christophe Legefakis.

“ANSM has a problem. Philips does not transmit information automatically. I think we have to move forward and the criminal justice system opens an investigation and appoints an investigative judge. With these items, we will eventually be able to get the information needed to reassure patients and tell the truth.”

For its part, the Paris Public Prosecutor’s Office, with whom we contacted, told us that it is studying several complaints. It has even declared itself concerned with at least one complaint in this Philips file. The Prosecution expects from all elements the possibility of opening a preliminary investigation and centralizing all complaints lodged in France.

#Sleep #apnea #Philips #remains #evasive #potentially #carcinogenic #devices

Leave a Comment

Your email address will not be published.